Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

BIOLOGICAL: NGM282
OTHER: Placebo

Sponsor

NGM Biopharmaceuticals, Inc

Collaborators

[object Object]